DEI vs JNJ · P/E 47, rev $507.5M vs P/E 17, rev $49.37B
Douglas Emmett Inc (DEI) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Douglas Emmett Inc (DEI) is a reit - office company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported DEI revenue for 2026-06-30 was $507.5M. Net income was -$5.2M. DEI currently screens at market cap $3.06B and trailing P/E 47.2.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
DEI currently screens at market cap $3.06B and trailing P/E 47.2. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the DEI and JNJ stock pages for the full models.
Not investment advice.